-
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:To identify the communication technologies used for remote healthcare sessions, how they are used, their accessibility, and their potential benefits and drawbacks for people with inflammatory bowel disease.The protocol can be found here.
April 20 2021
-
Infantile hypertrophic pyloric stenosis (IHPS) is a disorder of young children (aged one year or less) and can be treated by laparoscopic (LP) or open (OP) longitudinal myotomy of the pylorus. Since the first description in 1990, LP is being performed more often worldwide.Read the full review here.
March 9 2021
-
We are pleased to announce that we are expanding our Editorial Team. There are currently several vacancies for Contact and Statistical Editors to join Cochrane Gut. If you are interested in applying or learning more please click here for more information.
February 24 2021
-
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the efficacy and safety of donor‐based FMT versus control for the treatment of rCDI in immunocompetent participants.The protocol can be found here.
February 10 2021
-
The aim of this Cochrane Review was to find out whether antidepressants can improve symptoms in children and adolescents with functional abdominal pain disorders (FAPDs). We collected and analysed data from three studies with a total of 223 children and adolescents to answer this question.Read the full review here.
February 10 2021
-
Inflammatory bowel disease affects approximately seven million people globally. Iron deficiency anaemia can occur as a common systemic manifestation, with a prevalence of up to 90%, which can significantly affect quality of life, both during periods of active disease or in remission. It is important that iron deficiency anaemia is treated...
January 22 2021
-
Pancreatic and periampullary adenocarcinomas account for some of the most aggressive malignancies, and the leading causes of cancer‐related mortalities. Partial pancreaticoduodenectomy (PD) with negative resection margins is the only potentially curative therapy. The high prevalence of lymph node metastases has led to the hypothesis that wider...
January 22 2021
-
Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.Read the full review here.
October 27 2020
-
About half of patients with Crohn's disease (CD) require surgery within 10 years of diagnosis. Resection of the affected segment is highly effective, however the majority of patients experience clinical recurrence after surgery. Most of these patients have asymptomatic endoscopic recurrence weeks or months before starting with symptoms. This...
August 11 2020
-
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD. There is some evidence that probiotics benefit other...
July 17 2020
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:To identify the communication technologies used for remote healthcare sessions, how they are used, their accessibility, and their potential benefits and drawbacks for people with inflammatory bowel disease.The protocol can be found here.April 20 2021
Infantile hypertrophic pyloric stenosis (IHPS) is a disorder of young children (aged one year or less) and can be treated by laparoscopic (LP) or open (OP) longitudinal myotomy of the pylorus. Since the first description in 1990, LP is being performed more often worldwide.Read the full review here.March 9 2021
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:To assess the efficacy and safety of donor‐based FMT versus control for the treatment of rCDI in immunocompetent participants.The protocol can be found here.February 10 2021
The aim of this Cochrane Review was to find out whether antidepressants can improve symptoms in children and adolescents with functional abdominal pain disorders (FAPDs). We collected and analysed data from three studies with a total of 223 children and adolescents to answer this question.Read the full review here.February 10 2021
Inflammatory bowel disease affects approximately seven million people globally. Iron deficiency anaemia can occur as a common systemic manifestation, with a prevalence of up to 90%, which can significantly affect quality of life, both during periods of active disease or in remission. It is important that iron deficiency anaemia is treated...January 22 2021
Pancreatic and periampullary adenocarcinomas account for some of the most aggressive malignancies, and the leading causes of cancer‐related mortalities. Partial pancreaticoduodenectomy (PD) with negative resection margins is the only potentially curative therapy. The high prevalence of lymph node metastases has led to the hypothesis that wider...January 22 2021
Medications used to treat inflammatory bowel disease (IBD) have significantly improved patient outcomes and delayed time to surgery. However, some of these therapies are recognized to increase the general risk of infection and have an unclear impact on postoperative infection risk.Read the full review here.October 27 2020
About half of patients with Crohn's disease (CD) require surgery within 10 years of diagnosis. Resection of the affected segment is highly effective, however the majority of patients experience clinical recurrence after surgery. Most of these patients have asymptomatic endoscopic recurrence weeks or months before starting with symptoms. This...August 11 2020
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract, in which the pathogenesis is believed to be partly influenced by the gut microbiome. Probiotics can be used to manipulate the microbiome and have therefore been considered as a potential therapy for CD. There is some evidence that probiotics benefit other...July 17 2020